Laird Norton Wetherby Trust Company, LLC - ATHIRA PHARMA INC ownership

ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 71 filers reported holding ATHIRA PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
Laird Norton Wetherby Trust Company, LLC ownership history of ATHIRA PHARMA INC
ValueSharesWeighting
Q3 2023$360,992
-16.9%
178,709
+21.3%
0.05%
-9.8%
Q2 2023$434,562
+24.2%
147,309
+5.2%
0.05%
+15.9%
Q1 2023$350,000
-15.1%
140,000
+7.7%
0.04%
-25.4%
Q4 2022$412,100
+15.8%
130,000
+8.3%
0.06%
-27.2%
Q3 2022$356,000
-2.7%
120,0000.0%0.08%
+76.1%
Q2 2022$366,000
-66.1%
120,000
+50.0%
0.05%
-53.1%
Q1 2022$1,080,000
+3.6%
80,0000.0%0.10%
+1.0%
Q4 2021$1,042,000
+1020.4%
80,000
+700.0%
0.10%
+870.0%
Q3 2021$93,000
-8.8%
10,0000.0%0.01%
-9.1%
Q2 2021$102,00010,0000.01%
Other shareholders
ATHIRA PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
BML Capital Management, LLC 714,763$2,265,7992.16%
Perceptive Advisors 4,797,278$15,207,3710.43%
Potomac Capital Management, Inc. 80,000$2540.30%
Bristlecone Advisors, LLC 696,629$2,208,3140.27%
TANG CAPITAL MANAGEMENT LLC 485,234$1,538,1920.22%
RA Capital Management 1,881,300$5,963,7210.12%
GSA CAPITAL PARTNERS LLP 270,989$8590.11%
PATHSTONE FAMILY OFFICE, LLC 3,631,080$8,182,6500.07%
Laird Norton Wetherby Trust Company, LLC 130,000$412,1000.06%
Forefront Analytics, LLC 22,350$70,8510.04%
View complete list of ATHIRA PHARMA INC shareholders